Share on facebook Share on Twitter Share on Google Plus Share This
Back to Results

Philip W. Hinds, PhD


Training + Education Princeton University; Whitehead Institute
Gender Male
Accepted Insurances View Accepted Insurances at Tufts MC + Floating Hospital

Research Focus

Our research is focused on G1 cell cycle control and its dysregulation in cancer cells. Specifically, we are investigating the function of the retinoblastoma protein, (pRb), D-type cyclins, cdk4 and cdk6 in programs of cell cycle exit. Together, along with p16INK4a, a negative regulator of cdk4 and cdk6, these proteins regulate a critical decision making point in progression to S phase and thus DNA replication. In almost all human tumors, one of these proteins is lost or overexpressed, thus favoring proliferation and tumor growth. Although these proteins regulate S phase in response to genome integrity (DNA damage), we and others have shown that they are also critically involved in the permanent cell cycle withdrawal associated with differentiation and senescence.

Using complementary approaches incorporating biochemical methods, cell culture of primary and established cells, and animal models of development and cancer, we aim to identify key regulators of tumorigenesis with particular emphasis on breast cancer and osteosarcoma.

Contact Information

Phone: 617-636-7947

Email: Philip Hinds

Molecular Oncology Research Institute
Tufts Medical Center
800 Washington Street, Box #5609
Boston, MA 02111